Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CODD, E. E")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

1,3-Di(2-[5-3H]tolyl) guanidine labels more than one site in rat forebrainCODD, E. E; SHANK, R. P.European journal of pharmacology. 1992, Vol 217, Num 2-3, pp 149-152, issn 0014-2999Article

Lack of glibenclamide or TEA affinity for opioid receptors : further evidence for in vivo modulation of antinociception at K+ channelsRAFFA, R. B; CODD, E. E.Brain research. 1994, Vol 650, Num 1, pp 146-148, issn 0006-8993Article

Platelet serotonin uptake: methods and strain differencesCODD, E. E; WALKER, R. F.Psychiatry research. 1987, Vol 22, Num 1, pp 61-67, issn 0165-1781Article

Altered chemotactic peptide binding in tobacco smokers' neutrophilsCODD, E. E; BRIDGES, R. B.Regulatory peptides. 1986, Vol 14, Num 3, pp 243-251, issn 0167-0115Article

Daily patterns of serotonin uptake in platelets from psychiatric patients and control volunteersHUMPHRIES, L. L; SHIRLEY, P; ALLEN, M et al.Biological psychiatry (1969). 1985, Vol 20, Num 10, pp 1073-1081, issn 0006-3223Article

LiCl uncouples signal transduction in morphine-induced supraspinal antinociception in miceRAFFA, R. B; MARTINEZ, R. P; RENZI, M. J et al.General pharmacology. 1995, Vol 26, Num 2, pp 317-320, issn 0306-3623Article

Complementary and synergistic antinociceptive interaction between the enantiomers of tramadolRAFFA, R. B; FRIDERICHS, E; REIMANN, W et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 267, Num 1, pp 331-340, issn 0022-3565Article

Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesicRAFFA, R. B; FRIDERICHS, E; REIMAN, W et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 260, Num 1, pp 275-285, issn 0022-3565Article

Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orallyTAO, Q; STONE, D. J; BORENSTEIN, M. R et al.Journal of clinical pharmacy and therapeutics (Print). 2002, Vol 27, Num 2, pp 99-106, issn 0269-4727Article

A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/α1A-adrenergic affinity and a low potential for extrapyramidal effectsREITZ, A. B; BENNETT, D. J; BLUM, P. S et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 8, pp 1060-1062, issn 0022-2623Article

Intranasal activity of the growth hormone releasing peptide His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in conscious dogsNELSON, A. H; WALKER, R. F; CODD, E. E et al.Life sciences (1973). 1991, Vol 48, Num 23, pp 2283-2288, issn 0024-3205Article

A non-opioid pattern characterizes inhibition of growth hormone releasing peptide binding by dynorphin-related peptidesCODD, E. E; ALOYO, V. J; WALKER, R. F et al.Neuropeptides (Edinburgh). 1990, Vol 15, Num 3, pp 133-137, issn 0143-4179Article

Cyclic enkephalin analogues containing α-amino-β-mercapto-β,β-pentamethylenepropionic acid at positions 2 or 5BRYAN, W. M; CALLAHAN, J. F; CODD, E. E et al.Journal of medicinal chemistry (Print). 1989, Vol 32, Num 2, pp 302-304, issn 0022-2623, 3 p.Article

Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sitesCODD, E. E; SHU, A. Y. L; WALKER, R. F et al.Neuropharmacology. 1989, Vol 28, Num 10, pp 1139-1144, issn 0028-3908Article

α2 adrenoceptor agonists as potential analgesic agents. 1. (Imidazolylmethyl)oxazoles and -thiazolesBOYD, R. E; PRESS, J. B; HORTENSTEIN, J. T et al.Journal of medicinal chemistry (Print). 1999, Vol 42, Num 25, pp 5064-5071, issn 0022-2623Article

Piperazinylalkyl heterocycles as potential antipsychotic agentsSCOTT, M. K; BAXTER, E. W; ORTEGON, M. E et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 21, pp 4198-4210, issn 0022-2623Article

Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-famide (NPFF) and A-18-famide, for opioid μ, δ, κ1, κ2a, or κ2b receptorsRAFFA, R. B; KIM, A; RICE, K. C et al.Peptides (New York, NY. 1980). 1994, Vol 15, Num 3, pp 401-404, issn 0196-9781Article

Oral activity of the growth hormone releasing peptide HIS-D-TRP-ALA-TRP-D-PHE-LYS-NH2 in rats, dogs and monkeysWALKER, R. F; CODD, E. E; BARONE, F. C et al.Life sciences (1973). 1990, Vol 47, Num 1, pp 29-36, issn 0024-3205, 8 p.Article

  • Page / 1